The World Health Organisation (WHO) is planning to speak with the U.S. government and biotech firm Gilead …
"remdesivir"
-
-
International NewsNews
U.S. FDA grants emergency use for remdesivir for very sick coronavirus patients
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Gilead Sciences’ remdesivir drug …
-
Industry & TradeTech/AI
Gilead says remdesivir coronavirus treatment will need a ‘sustainable model’ to keep it accessible
Gilead Sciences is doing its best to make experimental antiviral drug remdesivir accessible and affordable to coronavirus …
-
Industry & TradeTech/AI
Gilead to produce ‘several million’ rounds of remdesivir to help treat coronavirus patients in 2021
Gilead Sciences said on Thursday that it can produce “several million” rounds of its antiviral drug remdesivir in …
-
It is too early to comment on the remdesivir “positive data” trial results released earlier on Wednesday, …
-
Industry & TradeTech/AI
U.S. FDA in ‘ongoing’ talks Gilead to make remdesivir available to coronavirus patients very soon
The U.S. Food and Drug Administration (FDA) said on Wednesday it has been in “sustained and ongoing” …
-
U.S. President Donald Trump said on Wednesday he wants the Food and Drug Administration to approve “as quickly …
-
US Gilead Sciences it is aware of “positive data” from one of its studies looking at antiviral …
-
Japan announced on Tuesday that it would approve remdesivir, a antiviral drug made by U.S. firm Gilead …
-
Industry & TradeTech/AI
New data on Gilead’s remdesivir – released by accident – shows it flops in first coronavirus clinical trial
Remdesivir developed by Gilead Sciences, a potential antiviral drug to treat coronavirus, has failed in its first …